PL1866650T3 - Neurodegeneracyjne markery depresji - Google Patents

Neurodegeneracyjne markery depresji

Info

Publication number
PL1866650T3
PL1866650T3 PL06723873T PL06723873T PL1866650T3 PL 1866650 T3 PL1866650 T3 PL 1866650T3 PL 06723873 T PL06723873 T PL 06723873T PL 06723873 T PL06723873 T PL 06723873T PL 1866650 T3 PL1866650 T3 PL 1866650T3
Authority
PL
Poland
Prior art keywords
depression
markers
disease
values
alzheimer
Prior art date
Application number
PL06723873T
Other languages
English (en)
Inventor
Aye Mu Myint
Manfred Schawaller
Robert Verkerk
Markus J Schwarz
NORBERT MüLLER
Original Assignee
Verstappen Leopold
Univ Of Maastricht
Univ Of Antwerp
Klinik Und Poliklinik Fuer Psychiatrie Und Psychotherapie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verstappen Leopold, Univ Of Maastricht, Univ Of Antwerp, Klinik Und Poliklinik Fuer Psychiatrie Und Psychotherapie filed Critical Verstappen Leopold
Publication of PL1866650T3 publication Critical patent/PL1866650T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
PL06723873T 2005-04-06 2006-03-30 Neurodegeneracyjne markery depresji PL1866650T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06
EP06723873A EP1866650B1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for depression.
PCT/EP2006/002907 WO2006105907A1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for psychiatric conditions

Publications (1)

Publication Number Publication Date
PL1866650T3 true PL1866650T3 (pl) 2011-04-29

Family

ID=36293430

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06723873T PL1866650T3 (pl) 2005-04-06 2006-03-30 Neurodegeneracyjne markery depresji
PL09013088T PL2146209T3 (pl) 2005-04-06 2006-03-30 Neurodegeneratywne markery choroby Alzheimera

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL09013088T PL2146209T3 (pl) 2005-04-06 2006-03-30 Neurodegeneratywne markery choroby Alzheimera

Country Status (14)

Country Link
US (2) US20080131921A1 (pl)
EP (2) EP1866650B1 (pl)
JP (1) JP4958893B2 (pl)
AT (2) ATE468537T1 (pl)
CY (1) CY1110116T1 (pl)
DE (1) DE602006014379D1 (pl)
DK (2) DK2146209T3 (pl)
ES (2) ES2377704T3 (pl)
HK (1) HK1137219A1 (pl)
NO (2) NO20075671L (pl)
PL (2) PL1866650T3 (pl)
PT (2) PT1866650E (pl)
SI (1) SI1866650T1 (pl)
WO (1) WO2006105907A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053405A4 (en) * 2006-08-04 2009-11-11 Ajinomoto Kk METHOD FOR EVALUATING STRESS, STRESS EVALUATION DEVICE, STRESS EVALUATION METHOD, STRESS EVALUATION SYSTEM, STRESS EVALUATION PROGRAM AND RECORDING MEDIUM
AT9843U1 (de) * 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
KR20220008944A (ko) 2008-01-18 2022-01-21 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
WO2009096502A1 (ja) * 2008-01-31 2009-08-06 Japan As Represented By President Of National Center Of Neurology And Psychiatry うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (en) * 2008-02-05 2009-08-13 University Of Miami Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
CN104777314B (zh) 2009-08-12 2017-01-04 福满代谢组技术有限公司 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质
JP2013538565A (ja) 2010-07-23 2013-10-17 プレジデント アンド フェロウズ オブ ハーバード カレッジ 体液中の疾患または症状のシグネチャを検出する方法
WO2012012725A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130184178A1 (en) 2010-07-23 2013-07-18 President And Fellows Of Harvard College Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
CN103797128B (zh) 2011-11-10 2016-09-07 福满代谢组技术有限公司 乙醇胺磷酸酯的测定方法
WO2013188828A1 (en) 2012-06-15 2013-12-19 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells
SG10201610508VA (en) 2012-06-15 2017-02-27 Harry Stylli Methods of detecting diseases or conditions
EP2914962A1 (en) 2012-11-05 2015-09-09 Ospedale San Raffaele S.r.l. Biomarkers of multiple myeloma development and progression
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
EP2965086A4 (en) 2013-03-09 2017-02-08 Harry Stylli Methods of detecting prostate cancer
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
EP3191846A4 (en) 2014-09-11 2018-06-13 Harry Stylli Methods of detecting prostate cancer
US11806385B2 (en) 2016-04-22 2023-11-07 Board Of Regents Of The University Of Nebraska Biomarkers for monitoring immune transformation
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
EP3688186A4 (en) * 2017-09-27 2021-10-13 University of North Carolina Wilmington HUMAN SEWAGE AND HUMAN-DERIVED PATHOGEN SEARCH TOOL
US20210041460A1 (en) * 2018-03-19 2021-02-11 Fujifilm Wako Pure Chemical Corporation Method for judging psychiatric disorder
CN111315420A (zh) * 2018-03-22 2020-06-19 株式会社日本医疗机器技研 生物可吸收支架
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
EP4067903A4 (en) * 2019-11-26 2024-03-06 Kyocera Corp LOAD MEASUREMENT SYSTEM AND LOAD MEASUREMENT METHOD
JP2023549028A (ja) * 2020-10-06 2023-11-22 学校法人沖縄科学技術大学院大学学園 アルツハイマー病（ａｄ）の診断のための指標を得るための方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (en) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
EP2146209A1 (en) 2010-01-20
ATE534038T1 (de) 2011-12-15
EP2146209B1 (en) 2011-11-16
PT2146209E (pt) 2011-12-30
JP4958893B2 (ja) 2012-06-20
DK1866650T3 (da) 2010-09-06
EP1866650B1 (en) 2010-05-19
CY1110116T1 (el) 2015-01-14
EP1866650A1 (en) 2007-12-19
HK1137219A1 (en) 2010-07-23
ATE468537T1 (de) 2010-06-15
JP2008537111A (ja) 2008-09-11
WO2006105907A1 (en) 2006-10-12
NO20120452L (no) 2007-11-06
US20120196300A1 (en) 2012-08-02
ES2377704T3 (es) 2012-03-30
PT1866650E (pt) 2010-06-01
DE602006014379D1 (de) 2010-07-01
NO20075671L (no) 2007-11-06
ES2346467T3 (es) 2010-10-15
SI1866650T1 (sl) 2010-12-31
PL2146209T3 (pl) 2012-05-31
DK2146209T3 (da) 2012-02-13
US20080131921A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
SI1866650T1 (sl) Nevrodegenerativni markerji za depresijo
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
WO2005047484A3 (en) Biomarkers for alzheimer's disease
HK1128684A1 (en) Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins
IL170574A (en) Method for measuring force-dependent gyroscope sensitivity
EP1700096A4 (en) PROOF OF PROTEINS AND PRIONS WITH CHANGED CONFORMATION
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2008021515A3 (en) Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
EP1855525A4 (en) FISH MODELS ZEBRA OF ALZHEIMER'S DISEASE
IL195288A0 (en) Procedure and methods for detecting alzheimer's disease
AU2010202926B2 (en) Markers and methods relating to the assessment of Alzheimer's disease
FR2874675B1 (fr) Frein pour roue avec capteur d'usure
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
AU2374302A (en) Means for detecting pathological transformation of the app protein and their uses
EP1604613A4 (en) CATHETER SENSOR FOR MEASURING HARDNESS
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
WO2007066129A3 (en) A method of detecting skeletal muscle damage
WO2004005534A3 (en) Screening for alzheimer's disease
ATE414904T1 (de) Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo
DK1639139T3 (da) Fremgangsmåder til påvisning af Alzheimers sygdom
WO2007066131A3 (en) A method of detecting skeletal muscle damage
GB0622194D0 (en) Method for diagnosing or detecting alzheimer's disease
HK1110388A1 (en) Fragment of neurosecretory protein vgf as a biomarker for alzheimer's disease
GB2431273B (en) Narrow inclined vehicle sensing region